Status:
COMPLETED
Evaluation of a Probiotic on LDL-cholesterol Levels
Lead Sponsor:
Biosearch S.A.
Conditions:
Cardiovascular Diseases
LDL-cholesterol
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The aim of the present study is to evaluate the ability of Bifidobacterium BSL\_PS404 in reducing LDL-cholesterol levels in healthy individuals.
Detailed Description
There is a strong correlation between LDL-cholesterol and cardiovascular diseases. Conjugated bile acids help to break down and emulsify dietary fat into micelles that promote their absorption by the...
Eligibility Criteria
Inclusion
- Levels of LDL-cholesterol between 100 and 190 mg/dL.
- Accept freely to participate in the study and sign the informed consent document.
Exclusion
- Be pregnant.
- Have planned to carry out a dietary intervention or exercise practice with the aim of losing weight in the coming weeks.
- Having a serious illness.
- Having diabetes.
- Having a cerebrovascular disease.
- Being allergic to any group of antibiotics.
- Take probiotics in the form of supplements at least 4 weeks before.
- Take antibiotics at least 4 weeks before.
- Being taking products or drugs to control cholesterol levels
Key Trial Info
Start Date :
May 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04029818
Start Date
May 24 2019
End Date
July 31 2019
Last Update
November 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital San Cecilio
Granada, Andalusia, Spain, 18016